The knockdown of endogenous HIPK2 in colon cancer cells augments the stability of β-catenin and the expression of β-catenin target genes, stimulating proliferation, increased wound healing and in vivo tumor growth [38]. The gene discussed is HIPK2; the disease is malignant colon neoplasm.